search
Back to results

Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB) (EEA-LGB)

Primary Purpose

Morbid Obesity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
3.5 mm vs 4.8 mm Stapler During Laparoscopic Gastric Bypass
Sponsored by
University of California, Irvine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Morbid Obesity focused on measuring Morbid Obesity, Laparoscopic Gastric Bypass, Staple Line Hemorrhage

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: BMI between 40-60 kg/m2 BMI of 35 kg/m2 with comorbidities Exclusion Criteria: large abdominal ventral hernia large hiatal hernia, history of liver cirrhosis history of venous thrombosis or pulmonary embolism, coagulopathy or Pregnant women All physician, hospital, surgery, and laboratory costs will be billed to the subject or their insurance carriers as customary. The 3.5mm circular stapler is an FDA approved product and it will also be billed to the subject or insurer in the customary fashion.

Sites / Locations

  • University of California, Irvine Medical Center
  • Tampa General Hospital- University of South Florida
  • Beth Israel Deaconess Medical Center
  • New York Presbyterian Hospital-Weill Cornell Medical Center
  • Ohio State University
  • UT Southwestern Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Smaller Stapler

Larger Stapler

Arm Description

3.5 mm Circular Stapler

4.8 mm Circular Stapler

Outcomes

Primary Outcome Measures

Number of Participants With Postoperative Gastrointestinal Hemorrhage

Secondary Outcome Measures

Full Information

First Posted
October 31, 2005
Last Updated
February 11, 2010
Sponsor
University of California, Irvine
Collaborators
United States Surgical Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT00254072
Brief Title
Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)
Acronym
EEA-LGB
Official Title
Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)a Prospective Randomized Comparison of the 3.5 mm vs 4.8 mm Circular Stapler for Creation of the Gastrojejunostomy in Prevention of Staple Line Hemorrhage During Laparoscopic Gastric Bypass
Study Type
Interventional

2. Study Status

Record Verification Date
February 2010
Overall Recruitment Status
Completed
Study Start Date
January 2007 (undefined)
Primary Completion Date
April 2009 (Actual)
Study Completion Date
April 2009 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University of California, Irvine
Collaborators
United States Surgical Corporation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Laparoscopic gastric bypass surgery is a common procedure being performed for the treatment of morbid obesity. The procedure consists of a creation of a small gastric pouch and rerouting the small bowel to bypass the stomach and duodenum. There are two anastomoses in this procedure: the gastrojejunostomy and the jejunojejunostomy. Potential complications after gastric bypass include gastrointestinal bleeding and leaks. Gastrointestinal bleeding can occur at any staple line including the gastrojejunostomy. Potential methods for prevention of postoperative gastrointestinal bleeding include oversewing of the anastomosis or the use of a smaller stapler height. We hypothesize that the use of staplers with smaller staple height will significantly result in a lower rate of staple line bleeding and possible leaks.
Detailed Description
RATIONALE: Gastrointestinal (GI) bleeding can occur in up to 4% of cases. GI bleeding is associated with significant morbidity which may include transfusion and possible re-operation Leaks at the gastrojejunostomy can be potentially life threatening and ranged from 1% to 2%. HYPOTHESES: The smaller circular stapler may be associated with a lower rate of intraoperative intraluminal bleeding and postoperative gastrointestinal bleeding than the larger one.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Morbid Obesity
Keywords
Morbid Obesity, Laparoscopic Gastric Bypass, Staple Line Hemorrhage

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
355 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Smaller Stapler
Arm Type
Active Comparator
Arm Description
3.5 mm Circular Stapler
Arm Title
Larger Stapler
Arm Type
Active Comparator
Arm Description
4.8 mm Circular Stapler
Intervention Type
Procedure
Intervention Name(s)
3.5 mm vs 4.8 mm Stapler During Laparoscopic Gastric Bypass
Other Intervention Name(s)
Covidien small 3.5 mm Circular Stapler, Covidien large 4.8 mm Circular Stapler
Intervention Description
The procedure consists of a creation of a small gastric pouch and rerouting the small bowel to bypass the stomach and duodenum. There are two anastomoses in this procedure: the gastrojejunostomy and the jejunojejunostomy.
Primary Outcome Measure Information:
Title
Number of Participants With Postoperative Gastrointestinal Hemorrhage
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: BMI between 40-60 kg/m2 BMI of 35 kg/m2 with comorbidities Exclusion Criteria: large abdominal ventral hernia large hiatal hernia, history of liver cirrhosis history of venous thrombosis or pulmonary embolism, coagulopathy or Pregnant women All physician, hospital, surgery, and laboratory costs will be billed to the subject or their insurance carriers as customary. The 3.5mm circular stapler is an FDA approved product and it will also be billed to the subject or insurer in the customary fashion.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ninh T Nguyen, MD
Organizational Affiliation
University of California, Irvine
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, Irvine Medical Center
City
Orange
State/Province
California
ZIP/Postal Code
92868
Country
United States
Facility Name
Tampa General Hospital- University of South Florida
City
Tampa
State/Province
Florida
ZIP/Postal Code
33601
Country
United States
Facility Name
Beth Israel Deaconess Medical Center
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02215
Country
United States
Facility Name
New York Presbyterian Hospital-Weill Cornell Medical Center
City
New York
State/Province
New York
ZIP/Postal Code
10021
Country
United States
Facility Name
Ohio State University
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43210-1228
Country
United States
Facility Name
UT Southwestern Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390-9156
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)

We'll reach out to this number within 24 hrs